| TOP CLASS HEALTHCARE, FI | RVI SALUD | 18,882990 | 19/11/2026 | 16,09% | 27,46% | ** |
| BGF WORLD HEALTHSCIENCE E2 EUR | RVI BIOTECNOLOGÍA | 65,690000 | 19/11/2026 | 16,08% | 29,80% | * |
| CANDRIAM SUSTAINABLE EQUITY EMERGING MARKETS V EUR CAP | RVI EMERGENTES | 1.635,680000 | 19/11/2026 | 16,08% | 56,18% | *** |
| INVESCO ASIAN EQUITY E CAP EUR | RVI ASIA EX-JAPÓN | 13,790000 | 19/11/2026 | 16,08% | 55,64% | ** |
| INVESCO UK EQUITY A CAP GBP | RVI UK | 17,360405 | 19/11/2026 | 16,08% | 59,04% | **** |
| JPM ASIA PACIFIC EQUITY A (DIST) USD | RVI ASIA EX-JAPÓN | 208,533479 | 19/11/2026 | 16,08% | 63,27% | **** |
| JPM GLOBAL EQUITY ABSOLUTE ALPHA C (PERF) (ACC) EUR | RENT. ABSOLUTA. | 120,350000 | 19/11/2026 | 16,08% | · | ND |
| MFS MERIDIAN ASIA EX-JAPAN FUND I1-USD | RVI ASIA EX-JAPÓN | 398,535298 | 19/11/2026 | 16,08% | 55,85% | *** |
| SCHRODER ISF ASIAN EQUITY YIELD C ACC EUR | RVI ASIA EX-JAPÓN VALOR | 305,800300 | 19/11/2026 | 16,08% | 62,06% | **** |
| UBAM - GLOBAL EQUITY UPC USD | RVI GLOBAL | 129,276076 | 18/11/2026 | 16,08% | · | ND |